Skip to content
August 19, 2022

Equity.Guru

Investment information for the new generation

Eyam

MYND Life Sciences (MYND.C) announced they have signed a Letter of Intent (LOI) with Eyam Vaccines and Immunotherapies which outlines an Exclusive Licensing Agreement with respect to Eyam’s proprietary…